ANGIOFIBROMA NASOFARINGEO JUVENIL PDF

ANGIOFIBROMA NASOFARINGEO JUVENIL PDF

Alves F RA, Granato L, Maia M S. Acessos Cirúrgicos no Angiofibroma Nasofaríngeo Juvenil – Relato de caso e revisão de literatura. Arch Otolaryngol Head. Juvenile angiofibroma (JNA) is a benign tumor that tends to bleed and occurs in the nasopharynx of prepubertal and adolescent males. Transcript of ANGIOFIBROMA JUVENIL NASOFARINGEO. Estadio I – tumor confinado a la nasofaríngeo. Estadio II – tumor extendido a la.

Author: Jutaxe Shaktizshura
Country: Myanmar
Language: English (Spanish)
Genre: Education
Published (Last): 19 October 2011
Pages: 432
PDF File Size: 19.85 Mb
ePub File Size: 8.44 Mb
ISBN: 116-2-16766-147-9
Downloads: 67392
Price: Free* [*Free Regsitration Required]
Uploader: Voshakar

These tumors occur almost exclusively in male angiotibroma and account for 0. Supply of these tumours is usually via Maurice M, Milad M. Intracranial juvenile nasopharyngeal angiofibroma.

Endoscopic surgery is less invasive than open surgery, causing less damage to the patient. Patients may present with life-threatening epistaxis.

Nasopharyngeal angiofibroma – Wikipedia

Mesothelioma Malignant solitary fibrous tumor. Recent advances in the treatment of juvenile angiofibroma. Tumour of the respiratory system. Endoscopic surgery alone or with other conventional techniques was safe for the treatment of angiofibromas of different stages. Non-surgical treatments are available, including the use of hormones estrogen, testosteroneradiation therapy, chemotherapy, and recently, embolization; however, surgery is considered the treatment of choice, with the route depending angiogibroma the stage of the tumor and the overall condition of the patient 11,12, Antiofibroma review our privacy policy.

  GAMUTS IN RADIOLOGY PDF

Thank you for updating your details.

Nasopharyngeal angiofibroma: Our experience and literature review

The recurrence rate of endoscopically resected tumors has been shown to be low, and we found that none of our 20 patients experienced tumor recurrence. The tumor is limited to the sphenopalatine foramen, nasopharynx, and nasal cavity without bone destruction. Nasopharyngeal angiofibroma[TI] free full text[sb]. Sociedade Brasileira de Otorrinolaringologia. Arterial embolization in the management of posterior epistaxis.

For example, a retrospective study of 15 patients found tumor recurrence nasofaringe 1 patient 6. Service chief medical residency in Otorhinolaryngology, Universidade Federal de Sergipe. Transcatheter arterial embolization in nasopharyngeal angiofibroma. Definitive Radiotherapy for Juvenile Nasopharyngeal Angiofibroma. Moreover, the mean blood loss in these patients was mL. National Center for Biotechnology InformationU.

Angiofibroma nasofaríngeo juvenil – Wikipedia, la enciclopedia libre

Recent advances in the treatment of juvenile angiofibroma. Examinations such as computed tomography, nuclear magnetic resonance and even nasal endoscopy can clearly establish the extent of angiofinroma tumor, its pattern of spread, and consequently, surgical planning 10 11 12 16 17 18 Open in a separate window. Arch Otolaryngol Head Neck Surg.

Introduction Nasopharyngeal angiofibroma is a histologically and biologically benign tumor with aggressive behavior due to its location and associated symptoms including significant epistaxis and nasal obstruction Our patients were classified using the Fisch system, the most widely used in most studies Figures 2 and 3. Blood loss, which was — mL in a non-embolized patient, was reduced to — mL in embolized patients 31 angiofibroam Retrospective, descriptive study conducted after approval from the Ethics Committee of the Federal University of Sergipe protocol Typically a lobulated non-encapsulated soft tissue mass is demonstrated centred on the sphenopalatine foramen which is often widened and usually bowing the posterior wall of the maxillary antrum anteriorly.

  BIRZIECIU ZODIS PDF

Nasopharyngeal angiofibroma also called juvenile nasopharyngeal angiofibroma [1] [2] is a histologically benign but locally aggressive vascular tumor that grows in the angipfibroma of the nasal cavity. In the 17 patients who underwent endoscopic approach alone, the mean operation time was min and the mean blood loss was mL; none required replacement of blood products.

To retrospectively describe our experience in the diagnosis and treatment of patients with juvenile nasopharyngeal angiofibroma. Several surgical approaches have been utilized for the removal of nasopharyngeal angiofibromas, including transnasal, transpalatal, transzygomatic, and transcervical accesses, in addition to lateral rhinotomy and mid-facial degloving, with or without extension to the upper lip or angiofbroma craniotomy 9.